Seaport Therapeutics, Inc. Common Stock SPTX · SEC Filings

website

Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinica...

Price21.925

Market Cap1.17 B

Float18.43 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 2, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jun 8, 2026

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B4

IPO | Offering amount: $254,880,000 | Shares: 14,160,000 | Price: $18.000 | Bank: Goldman Sachs & Co. LLC; J.P. Morgan; Leerink Partners; Citigroup; Stifel

May 1, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 1, 2026

S-1MEF

OFFERING

Apr 30, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Apr 28, 2026

S-1/A

OFFERING - IPO | Bank: Goldman Sachs & Co. LLC

Apr 27, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Apr 10, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Feb 27, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Torres Denice (Reporting)

Nov 4, 2026

SCHEDULE 13G

PureTech LYT, Inc. (Filed by)

Aug 14, 2026

SCHEDULE 13G

Zohar Daphne (Filed by)

Aug 5, 2026

SCHEDULE 13G

PAUL STEVEN M (Filed by)

Aug 5, 2026

HOMBACH ROBERT J. (Reporting)

Jun 24, 2026

SCHEDULE 13D

GENERAL ATLANTIC, L.P. (Filed by)

May 11, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 1, 2026